Vali, Y; Wonders, K; Aithal, G; Aller, R; Allison, M; Arola, J; Banales, JM; Bernal, V; Berzigotti, A; Boursier, J; Brass, C; Bugianesi, E; Panero, JLC; Cobbold, J; Cortez-Pinto, H; Crespo, J; Davies, S; Driessen, A; Duffin, K; Ekstedt, M; Forton, D; Fournier-Poizat, C; Francque, S; Geier, A; Gouw, A; Hagström, H; Holleboom, AG; Hytiroglou, P; Karsdal, M; Lackner, C; Leeming, DJ; Magnanensi, J; Mayo, R; Miele, L; Papatheodoridis, G; Paradis, V; Pavlides, M; Pericàs, JM; Petta, S; Ratziu, V; Romero-Gómez, M; Schattenberg, JM; Schuppan, D; Surabattula, R; Silva, A; Straub, B; Kjaer, M; Svegliati-Baroni, G; Tiniakos, DG; Tonini, MM; Torstenson, R; Valenti, L; Verheij, J; Wenn, D; Yki-Järvinen, H; Yunis, C; Bossuyt, P; Anstee, QM.
Comprehensive analysis of biomarker performance targeting "advanced fibrosis" and "at-risk" metabolic-dysfunction associated steatotic liver disease (MASH)-primary analysis of the LITMUS study cohort
J HEPATOL. 2025; 82:
Web of Science